BRIEF

on DIAGNOSTIC MEDICAL (EPA:ALDMS)

Diagnostic Medical Systems: revenue growth in the 3rd quarter of 2024

Stock price chart of DIAGNOSTIC MEDICAL (EPA:ALDMS) showing fluctuations.

The Diagnostic Medical Systems (DMS) group recorded a 13% increase in its turnover in the third quarter of 2024, totaling 10 million euros. This increase is part of a positive dynamic for digital radiology and bone densitometry, in France and internationally.

In the first nine months of 2024, sales reached 32.9 million euros, an increase of 11% compared to the previous year. Radiology sales accounted for 78% of sales and increased by 14%.

DMS has notably integrated artificial intelligence into its systems, with the ADAM software applied to radiology mobiles. Launch of the Onyx mobile, winner of the Innovation Prize, planned for early 2025.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all DIAGNOSTIC MEDICAL news